Evaluation of proinflammatory cytokines In chronic lower limb ischaemia diabetic macroangiopathy and arteriosclerosis obliterans;Ocena wybranych cytokin prozapalnych w przewleklłym niedokrwieniu kończyn w przebiegu makroangiopatii cukrzycowej i miażdżycy zarostowej

Polski Merkuriusz Lekarski

Volumn 27, Issue 162, 2009, Pages 458-462

  Zdrojowy, Krystyna ^a,b   Knapik Kordecka, Maria ^a,b   Jakobsche Policht, Urszula ^a,b   Adamiec , Rajmund ^a,b  

^a Nadcisnienia Tetniczego i Diabetologii   (Poland)

^b Hypertension and Diabetology   (Poland)

Author keywords

Adhesion molecules; Atherogenic risk factor; Chronic lower limb ischaemia; Proinflammatory cytokines

Indexed keywords

CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; DIABETIC ANGIOPATHY; DISEASE COURSE; FEMALE; HUMAN; ISCHEMIA; LEG; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; VASCULARIZATION;

ARTERIOSCLEROSIS OBLITERANS; CYTOKINES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; E-SELECTIN; FEMALE; HUMANS; INTERLEUKIN-6; ISCHEMIA; LEG; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 74049113280     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Beckman J.A., Crager M.A., Libby P.: Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA, 2002, 287, 2570-2581.
2. Bevicquila M.P.: Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol., 1993, 11, 767.
3. Blann A., Mom's J., McCollum C: Soluble L-selectin in peripheral arterial disease: relationship with soluble E-selectin and soluble P-selectin. Atherosclerosis, 1996, 25, 126(2), 227-231.
4. Brownlee M.: Glycation and diabetic complication. Diabetes Care, 1994, 43, 836-841.
5. Criqui H.M.: Peripheral arterial disease: epidemiological aspects. Vascular Med., 200, 16, supl.1, 3-7.
6. DiMario U., Pugliese G.: Golgi lecture: from hyperglycemia to the dys-regulation of vascular remodeling in diabetes. Diabetologia, 2001, 44, 674-692.
7. Dolan N.C., Liu K., Criqui M.H., Greenland P., Guralnik J.M.: Peripheral artery disease, diabetes, and reduced lower extremity functioning. Diabetes Care, 25, 113-120, 2002.
8. Fiotti N., Giansante C, Ponte E., Delbello C, Calabrese S., Zacchi T, Dobrina A., Guarnieri G.: Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis, 1999, 145, 51-60.
9. Hotamisligil G.S., Amer P., Cara J.F., Atkinson R.L., Spiegelman B.M.: Increased adipose expression of tumor necrosis factor-in human obesity and insulin resistance. J. Clin. Invest., 1995, 95, 2409-2415.
10. Jilma B., Fasching P., Ruthner C: Circulating E-selectin in insulin dependent diabetes mellitus. Thromb. Haemost., 1996, 76, 328.
11. Kern P.A., Saghizadeh M., Ong J.M., Bosch R.J., Deem R., Simsolo R.B.: The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest., 1995, 95, 2111-2119.
12. Li D., Yang B., Mehta Jawakow L.: Tumor necrosis factor-α enhances hypoxia-reoxygenation mediated apoptosis in cultured human coronary artery endothelial cells: critical role of protein kinase C. Cardiovascular Research, 1999, 42, 805-813.
13. Libby P.: The vascular biology of atherosclerosis. Heart Disease. A textbook of cardiovascular medicine. W.B.Saunders Company 2001, 995.
14. Marhoffer W., Stein M" Maeser E., Federlin K.: Impairment of polymorphonuclear leucocyte function and metabolic control of diabetes. Diabetes Care, 1992, 15, 256-260.
15. McDermott M.M., Guralnik J.M., Corsi A., Albay M., Macchi C, Bandinelli S., Ferrucci L.: Patterns of inflamation associated with peripheral arterial disease: The In CHIANTI study. Am. Heart. J., 2005, 150, 276-281.
16. Molier D.: Potential role of TNF-α tin the pathogenesis of insulin resistance and type 2 diabetes. TEM, 2000, 11, 212-217.
17. Nylaende M., Kroese A., Stranden E., Morken B., Sandbaek G., Lindahl A.K., Amesen H., Seljeflot I.: Markers of vascular inflammation are associated with the extent of atheroslerosis assessed as angiographic score and treadmill walking diastance in patients with peripheral arterial occlusive disease. Vasc. Med., 2006, 11, 21-28.
18. Old L.J.: Tumor necrosis factor (TNF). Science, 1985, 230, 630-632.
19. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H.: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998, 97, 425-428.
20. Rosenberg R.D., Aird W.C.: Vascular bed-specific hemostasis and hy-percoagulable states. N. Engl. J. Med., 1999, 340, 1555-1564.
21. Ross R.: The pathogenesis of atherosclerosis. Nature, 1993, 362, 801-809.
22. Schreyer S.A., Streamson CC, LeBoeuf R.C.: Obesity and diabetes in TNF-rx receptor-dificient mice. J. Clin. Invest, 1998, 102, 402.
23. Signorelli S.S., Mazzarino M.C., Spandidos D.A., Malaponte G.: Proinflammatory circulating molecules in peropheral arterial disease. Int. J. Mol. Med., 2007, 20, 279-286.
24. Skolnik E.Y., Marcusohn J.: Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus. Cytokine and Growth Factor Reviews, 1996, 7, 2, 161-173.
25. Youd J.M., Rattigan S., Clark MG.: Acute impairment of insulin-mediated cappilary recruitment and glucose uptake in rat skeletal muscle in vivo by TNF-cc Diabetes, 2000, 49, 1904-1909.